Anna‐Kaisa Rimpelä
- Ophthalmology top 5%
- Retinal Diseases and Treatments 6
- Glaucoma and retinal disorders 2
- Retinal and Optic Conditions 1
- Pharmaceutical Science top 10%
-
- melanin and skin pigmentation 5
-
- Retinal Development and Disorders 7
- Protein Interaction Studies and Fluorescence Analysis 4
- Retinoids in leukemia and cellular processes 2
-
- Drug Transport and Resistance Mechanisms 2
Anna‐Kaisa Rimpelä
12 papers receiving 286 citations
Peers
Comparison fields: 5 of 65
- Ophthalmology 130
- Pharmaceutical Science 41
- Cell Biology 46
- Radiology, Nuclear Medicine and Imaging 64
- Molecular Biology 133
Countries citing papers authored by Anna‐Kaisa Rimpelä
This map shows the geographic impact of Anna‐Kaisa Rimpelä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna‐Kaisa Rimpelä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna‐Kaisa Rimpelä more than expected).
Fields of papers citing papers by Anna‐Kaisa Rimpelä
This network shows the impact of papers produced by Anna‐Kaisa Rimpelä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna‐Kaisa Rimpelä. The network helps show where Anna‐Kaisa Rimpelä may publish in the future.
Co-authorship network
The 21 scholars most cited alongside Anna‐Kaisa Rimpelä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2021 | 8 | |
| 3 | 2020 | 8 | |
| 4 | 2020 | 30 | |
| 5 | 2019 | 3 | |
| 6 | 2018 | 29 | |
| 7 | 2018 | 19 | |
| 8 | 2018 | 39 | |
| 9 | 2017 | 92 | |
| 10 | 2016 | 15 | |
| 11 | 2016 | 33 | |
| 12 | 2016 | 4 | |
| 13 | Ocular melanin binding of drugs: in vitro binding studies combined to a pharmacokinetic model | 2014 | 0 |
About Anna‐Kaisa Rimpelä
Anna‐Kaisa Rimpelä is a scholar working on Ophthalmology, Cell Biology and Biophysics, having authored 13 papers that have together received 288 indexed citations. Recurring topics across this work include Retinal Development and Disorders (7 papers), Retinal Diseases and Treatments (6 papers), melanin and skin pigmentation (5 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers), Retinoids in leukemia and cellular processes (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Glaucoma and retinal disorders (2 papers) and Retinal and Optic Conditions (1 paper). The work is most often cited by research in Ophthalmology (130 citations), Pharmaceutical Science (41 citations) and Cell Biology (46 citations). Anna‐Kaisa Rimpelä has collaborated with scholars based in Finland, Germany and Russia. Frequent co-authors include Arto Urtti, Heidi Kidron, Marja Hagström, Laura Hellinen, Mika Reinisalo, Eva M. del Amo, José A. Manzanares, Feng Deng, Achim Sauer and Maxim Antopolsky. Their work appears in journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.